Cargando…
Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy
Aim: The use of β-blocker therapy in asymptomatic patients with hypertrophic cardiomyopathy is controversial. This study evaluates the effect of lifestyle changes and high-dose β-blocker therapy on their exercise capacity. Methods and results: A total of 29 consecutive newly diagnosed asymptomatic p...
Autores principales: | Bratt, Ewa-Lena, Östman-Smith, Ingegerd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411744/ https://www.ncbi.nlm.nih.gov/pubmed/24607033 http://dx.doi.org/10.1017/S1047951114000237 |
Ejemplares similares
-
Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
por: Östman-Smith, Ingegerd
Publicado: (2014) -
Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy
por: Östman-Smith, Ingegerd, et al.
Publicado: (2010) -
Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy
por: Javidgonbadi, Davood, et al.
Publicado: (2019) -
What Aspects of Phenotype Determine Risk for Sudden Cardiac Death in Pediatric Hypertrophic Cardiomyopathy?
por: Östman-Smith, Ingegerd
Publicado: (2022) -
Determinants of Exercise Capacity in Patients With Hypertrophic Cardiomyopathy
por: Hwang, Ji-won, et al.
Publicado: (2022)